tiprankstipranks
Chimeric Therapeutics Ltd. (AU:CHM)
ASX:CHM
Australian Market

Chimeric Therapeutics Ltd. (CHM) Income Statement

Compare
8 Followers

Chimeric Therapeutics Ltd. Income Statement

Last quarter (Q4 2024), Chimeric Therapeutics Ltd.'s total revenue was AU$-1.76M, a decrease of -348.85% from the same quarter last year. In Q4, Chimeric Therapeutics Ltd.'s net income was AU$-14.97M. See Chimeric Therapeutics Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 24Jun 23Jun 22Jun 21Jun 20
Total Revenue
AU$ 7.46MAU$ 4.51MAU$ 2.62MAU$ 2.65KAU$ 0.00
Gross Profit
AU$ 7.45MAU$ 3.54MAU$ 1.67MAU$ -844.31KAU$ 0.00
Operating Expenses
AU$ 19.77MAU$ 28.52MAU$ 17.19MAU$ 14.85MAU$ 64.01K
Depreciation and Amortization
AU$ 1.01MAU$ 965.35KAU$ 949.76KAU$ 846.96KAU$ 153.62K
EBITDA
AU$ -11.30MAU$ -24.02MAU$ -13.62MAU$ -14.00MAU$ 0.00
Operating Income
AU$ -12.31MAU$ -29.49MAU$ -13.82MAU$ -15.11MAU$ -64.01K
Other Income/Expenses
AU$ -3.97MAU$ 4.08MAU$ -627.15KAU$ -3.23KAU$ 3.00
Pretax Income
AU$ -16.28MAU$ -30.33MAU$ -14.46MAU$ -15.11MAU$ -64.01K
Net Income
AU$ -12.53MAU$ -25.92MAU$ -14.62MAU$ -15.11MAU$ -64.01K
Per Share Metrics
AU$ ―AU$ ―AU$ ―AU$ ―AU$ ―
Basic EPS
AU$ -0.02AU$ -0.06AU$ -0.04AU$ -0.05AU$ 0.00
Diluted EPS
AU$ -0.02AU$ -0.06AU$ -0.04AU$ -0.05AU$ 0.00
Weighted Average Shares Outstanding
695.68M 433.24M 359.93M 325.51M 342.92M
Weighted Average Shares Outstanding (Diluted)
695.64M 433.24M 359.93M 325.50M 342.92M
Currency in AUD

Chimeric Therapeutics Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis